Carlsmed is a commercial-stage medical technology leader and creator of the personalized spine surgery market with pioneering technology that is transforming spine surgery. The Company has developed the cutting-edge aprevo® Technology Platform that personalizes surgical procedures through a combination of proprietary AI-driven software and patient-specific fusion devices. Show more Show less
$53M sweet spot round size
2018
$53M
from 2 investors over 1 rounds
Carlsmed raised $53M on April 18, 2024
Investors: B Capital and U.S. Venture Partners